Search
Innate Pharma SA
IPHAAdd to Watchlist
2.010USD
+0.150+8.06%
Close 09-16 16:00（ET）
188.34MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+8.06%
5 Days
+3.08%
1 Month
-7.80%
6 Months
+42.55%
Year to Date
+14.86%
1 Year
-3.37%
Key Figures
1.860Open
2.200High
20.73KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.02%Turnover Ratio
1.860Prev. Close
1.840Low
40.43KTurnover
LossP/E Static
-7.53P/B
0.00%Div Yield TTM
-33.51%ROA
2.71052wk High
0.95Volume Ratio
-49.47MNet Profit
93.70MShares
-0.5892EPS TTM
0.28Beta
-162.91%ROE
1.17052wk Low
18.28%Amplitude
100.00%Gross Margin
188.34MMarket Cap
7.21Reward/Risk
6.25%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
Innate Pharma SA Technical Analysis
Technical Indicators
Neutral
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
--/--
Revenue / Forecast
--/--
Innate Pharma SA Profile
SectorBiotechnology & Medical Research
Ticker SymbolIPHA
Number of employees181
CountryFrance
Ownership
| Shareholders | Proportion |
|---|---|
| AstraZeneca PLC | 1.67% |
| Lion Point Capital, L.P. | 0.09% |
| Morgan Stanley & Co. International Plc | 0.05% |
| Jane Street Capital, L.L.C. | 0.05% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 1.67% |
| Research Firm | 0.15% |
| Hedge Fund | 0.11% |
| Investment Advisor | 0.04% |
Related Instruments
+0.15%
+0.03%
+0.64%
-0.20%
+0.78%
+0.06%
+0.19%
+0.94%
-0.33%
-1.93%
-0.27%
-0.20%
-1.36%
+0.56%
+0.45%
+0.06%
+0.50%
-0.32%
+1.29%
-0.05%
FAQs
What is the current price of Innate Pharma SA (IPHA)?
The current price of Innate Pharma SA (IPHA) is 2.01.
What is the symbol of Innate Pharma SA?
The ticker symbol of Innate Pharma SA is IPHA.
What is the 52-week high of Innate Pharma SA?
The 52-week high of Innate Pharma SA is 2.71.
What is the 52-week low of Innate Pharma SA?
The 52-week low of Innate Pharma SA is 1.17.
What is the market capitalization of Innate Pharma SA?
The market capitalization of Innate Pharma SA is 188.34M.
Is Innate Pharma SA (IPHA) currently rated as Buy, Hold, or Sell?
According to analysts, Innate Pharma SA (IPHA) has an overall rating of Buy, with a price target of 7.13.
What is the Earnings Per Share (EPS TTM) of Innate Pharma SA (IPHA)?
The Earnings Per Share (EPS TTM) of Innate Pharma SA (IPHA) is -0.59.